CTRI/2023/09/058050进行中（未招募）2 期
A Randomized Placebo Control Study To Evaluate The Efficacy Of Individualized Homoeopathic Medicines In Cases Of Haemorrhoids - NI
Jawaharlal Nehru Homoeopathic Medical College & Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Pre-diagnosed cases, New diagnosed cases .
- •2. Following cases were included irrespective of their sex, caste, religion.
- •3. Patient of age group 18 - 60 years (both gender) from all socioeconomic status.
- •4. Diagnosed cases of Haemorrhoids who have taken medicines from any other system of treatment like Allopathy, Ayurvedic, etc, were also be considered after a washout period of 15 days.
- •5. Patients who have taken previously Homoeopathy medicines prior to the visit were also taken into consideration after 1 month of washout period.
- •6. The patients who have given their consent to participate in study with follow ups.
排除标准
- •1. The cases which did not fulfil the inclusion criteria.
- •2. Patient having Haemorrhoids in association with other autoimmune disorders.
- •3. Cases with other advanced pathology.
- •4. 4th Degree Prolapse of Rectum.
- •5. Pregnant women and lactating mothers.
- •6. Patients not giving written consent.
- •7. Cases with irregular follow up
研究者
相似试验
尚未招募
2 期
A study to evaluate the effect of AYUSH SR as adjunct to usual care for cardiac rehabilitation on biochemical, physical and psychological parameters, in adult patients who underwent Coronary Artery Bypass Graft (CABG) surgeryCTRI/2023/09/057564Central Council for Research in Ayurvedic Science (CCRAS) Ministry of AYUSH, Government of India
进行中（未招募）
不适用
Safety and efficacy of tocilizumab in combination with placebo compared with tocilizumab in combination with methotrexate, with possible addition of other disease-modifying antirheumatic drugs (DMARDs), in patients with moderate to severe active rheumatoid arthritis who are not responding adequately to their current therapy with methotrexateRheumatoid ArthritisEUCTR2008-001847-20-LVF Hoffmann-La Roche Ltd.470
进行中（未招募）
不适用
Safety and efficacy of tocilizumab in combination with placebo compared with tocilizumab in combination with methotrexate, with possible addition of other disease-modifying antirheumatic drugs (DMARDs), in patients with moderate to severe active rheumatoid arthritis who are not responding adequately to their current therapy with methotrexateMedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2008-001847-20-SEF Hoffmann-La Roche Ltd.470
进行中（未招募）
不适用
Safety and efficacy of tocilizumab in combination with placebo compared with tocilizumab in combination with methotrexate, with possible addition of other disease-modifying antirheumatic drugs (DMARDs), in patients with moderate to severe active rheumatoid arthritis who are not responding adequately to their current therapy with methotrexateMedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2008-001847-20-DEF Hoffmann-La Roche Ltd.470
进行中（未招募）
不适用
Safety and efficacy of tocilizumab in combination with placebo compared with tocilizumab in combination with methotrexate, with possible addition of other disease-modifying antirheumatic drugs (DMARDs), in patients with moderate to severe active rheumatoid arthritis who are not responding adequately to their current therapy with methotrexateMedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2008-001847-20-DKF Hoffmann-La Roche Ltd.470